AstraZeneca Shares Fall After Disappointing Cancer Drug Trial AstraZeneca’s shares experienced a decline after the pharmaceutical company reported disappointing results from a clinical trial...
AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec....